Li, D., & Xiao, D. (2017). Association between the XRCC1 polymorphisms and clinical outcomes of advanced NSCLC treated with platinum-based chemotherapy: A meta-analysis based on the PRISMA statement. BMC Cancer.
Dyfyniad Arddull ChicagoLi, Dan-Juan, and Dong Xiao. "Association between the XRCC1 Polymorphisms and Clinical Outcomes of Advanced NSCLC Treated With Platinum-based Chemotherapy: A Meta-analysis Based On the PRISMA Statement." BMC Cancer 2017.
Dyfyniad MLALi, Dan-Juan, and Dong Xiao. "Association between the XRCC1 Polymorphisms and Clinical Outcomes of Advanced NSCLC Treated With Platinum-based Chemotherapy: A Meta-analysis Based On the PRISMA Statement." BMC Cancer 2017.
Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.